rlbp1b

Summary

Gene Symbol: rlbp1b
Description: retinaldehyde binding protein 1b
Alias: CRALBPb, rlbp1, zgc:77766, retinaldehyde binding protein 1b, cralbpa, retinaldehyde binding protein 1, rlbp1a
Species: zebrafish

Top Publications

  1. Thomas J, Ranski A, Morgan G, Thummel R. Reactive gliosis in the adult zebrafish retina. Exp Eye Res. 2016;143:98-109 pubmed publisher
    ..Interestingly, when cell cycle inhibition is released, a partial recovery of regeneration is observed. Together, these data demonstrate that zebrafish Müller glia possess both gliotic and regenerative potential. ..
  2. Collery R, McLoughlin S, Vendrell V, Finnegan J, Crabb J, Saari J, et al. Duplication and divergence of zebrafish CRALBP genes uncovers novel role for RPE- and Muller-CRALBP in cone vision. Invest Ophthalmol Vis Sci. 2008;49:3812-20 pubmed publisher
    ..Recent evidence suggests a role for Müller glia in an alternate cone visual cycle. In this study, the role of RPE- and Müller-CRALBP in cone vision was characterized...
  3. Fleisch V, Schonthaler H, von Lintig J, Neuhauss S. Subfunctionalization of a retinoid-binding protein provides evidence for two parallel visual cycles in the cone-dominant zebrafish retina. J Neurosci. 2008;28:8208-16 pubmed publisher
  4. Jiang C, Qin B, Liu G, Sun X, Shi H, Ding S, et al. MicroRNA-184 promotes differentiation of the retinal pigment epithelium by targeting the AKT2/mTOR signaling pathway. Oncotarget. 2016;7:52340-52353 pubmed publisher
    ..MiR-184 promotes RPE differentiation via inhibiting the AKT2/mTOR signaling pathway. MiR-184 based supplementary therapeutics and mTOR blocker, like rapamycin, are prospective options for AMD treatment. ..
  5. Chen X, Sheng X, Zhuang W, Sun X, Liu G, Shi X, et al. GUCA1A mutation causes maculopathy in a five-generation family with a wide spectrum of severity. Genet Med. 2017;19:945-954 pubmed publisher
    ..The diverse pathogenic modes of GUCA1A mutations may explain the phenotypic diversities.Genet Med advance online publication 26 January 2017. ..